Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: A phase IIa study of the AGO Study Group
| Autor: | Baumann, K., Pfisterer, J., Wimberger, P., Burchardi, N., Kurzeder, C., du Bois, A., Loibl, S., Sehouli, J., Huober, J., Schmalfeldt, B., Vergote, I., Lück, H.J., Wagner, U. |
|---|---|
| Zdroj: | In Gynecologic Oncology 2011 123(1):27-32 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect